Where companies are testing COVID-19 therapies and vaccines: Data Byte

The U.S. remains the hotbed of COVID-19 therapeutics testing, but China is conducting almost as many vaccine trials. 

As of Jan. 25, there were over 700 active COVID trials listed in public registries that had yet to read out, of which 87% were testing therapeutics, according to BioCentury’s COVID-19 Clinical Trials Dashboard...